C

Classys Inc
KOSDAQ:214150

Watchlist Manager
Classys Inc
KOSDAQ:214150
Watchlist
Price: 57 300 KRW 0.35% Market Closed
Market Cap: ₩3.7T

EV/OCF

21.8
Current
33%
Cheaper
vs 3-y average of 32.4

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
21.8
=
Enterprise Value
₩3.6T
/
Operating Cash Flow
₩163.9B

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
21.8
=
Enterprise Value
₩3.6T
/
Operating Cash Flow
₩163.9B

Valuation Scenarios

Classys Inc is trading below its 3-year average

If EV/OCF returns to its 3-Year Average (32.4), the stock would be worth ₩85 274.29 (49% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-54%
Maximum Upside
+49%
Average Downside
2%
Scenario EV/OCF Value Implied Price Upside/Downside
Current Multiple 21.8 ₩57 300
0%
3-Year Average 32.4 ₩85 274.29
+49%
5-Year Average 29.6 ₩77 909.42
+36%
Industry Average 13.6 ₩35 683.2
-38%
Country Average 10 ₩26 232.18
-54%

Forward EV/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward EV/OCF

Peer Comparison

All Multiples
EV/OCF
P/E
All Countries
Close
Market Cap EV/OCF P/E
KR
Classys Inc
KOSDAQ:214150
3.7T KRW 21.8 26.9
US
Intuitive Surgical Inc
NASDAQ:ISRG
171.7B USD 54.7 60.1
US
Abbott Laboratories
NYSE:ABT
159.2B USD 16.7 25.4
US
Stryker Corp
NYSE:SYK
126B USD 27.1 38.8
IE
Medtronic PLC
NYSE:MDT
106.8B USD 17.3 23.2
US
Boston Scientific Corp
NYSE:BSX
96.2B USD 23.3 33.2
DE
Siemens Healthineers AG
XETRA:SHL
41.6B EUR 15.9 19.3
US
Edwards Lifesciences Corp
NYSE:EW
47.3B USD 27.2 44.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
46.1B USD 39.3 43.5
US
Becton Dickinson and Co
NYSE:BDX
44.3B USD 17.8 25.2
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
32.5B USD 18.9 15.6

Market Distribution

Higher than 73% of companies in Korea
Percentile
73nd
Based on 974 companies
73nd percentile
21.8
Low
0 — 5.8
Typical Range
5.8 — 18.7
High
18.7 —
Distribution Statistics
Korea
Min 0
30th Percentile 5.8
Median 10
70th Percentile 18.7
Max 2 215 163.4

Classys Inc
Glance View

Market Cap
3.7T KRW
Industry
Health Care

Classys Inc., a South Korean powerhouse in the world of aesthetic medical devices, has carved a niche for itself by capitalizing on the soaring demand for non-invasive beauty treatments. Founded in 2007, the company quickly identified a growing market shift towards minimally invasive procedures, and leveraged its technological prowess to develop cutting-edge solutions. Focusing on continuous innovation, Classys has developed a robust portfolio of high-quality products, including popular devices like Clatuu Alpha for fat reduction and Ultraformer for skin lifting. These devices cater to clinics and professionals seeking reliable, effective solutions for their clients' aesthetic needs. The company strategically invests in research and development to stay ahead in this highly competitive sector, continually upgrading its offerings to suit market trends. Operating in over 60 countries, Classys has effectively harnessed the power of global distribution networks and strategic partnerships to bolster its market presence. The company's business model primarily revolves around direct sales and distribution agreements, generating revenue by selling advanced aesthetic devices to medical professionals, clinics, and distributors worldwide. By providing training and after-sales services, Classys ensures customer satisfaction and fosters long-term relationships, which are crucial for repeat business. Additionally, its strong emphasis on compliance with international safety standards and certifications has bolstered its reputation, enabling the company to expand its footprint in emerging markets. This strategic approach has allowed Classys to maintain steady growth in an industry where technological advancements and consumer preferences are in constant flux.

Intrinsic Value
57 469.23 KRW
Fairly Valued
Intrinsic Value
Price ₩57 300
C
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett